FGFR2 genetic variants in women with breast cancer
- Authors:
- Thérèse Dix-Peek
- Caroline Dickens
- Tanya N. Augustine
- Boitumelo P. Phakathi
- Eunice J. Van Den Berg
- Maureen Joffe
- Oluwatosin A. Ayeni
- Herbert Cubasch
- Sarah Nietz
- Christopher G. Mathew
- Mahtaab Hayat
- Alfred I. Neugut
- Judith S. Jacobson
- Paul Ruff
- Raquel A.B. Duarte
-
Affiliations: Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of The Witwatersrand, Johannesburg 2193, South Africa, School of Anatomical Sciences, Faculty of Health Sciences, University of The Witwatersrand, Johannesburg 2193, South Africa, Department of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of Kwa-Zulu Natal, Durban 4001, South Africa, Department of Histopathology, National Health Laboratory Services, Chris Hani Baragwanath Hospital, Johannesburg 1864, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of The Witwatersrand, Johannesburg 2193, South Africa, South African Medical Research Council Common Epithelial Cancer Research Centre, Faculty of Health Sciences, University of The Witwatersrand, Johannesburg 2193, South Africa, Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of The Witwatersrand, Johannesburg 2193, South Africa, Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, New York 10032, United States of America - Published online on: October 10, 2023 https://doi.org/10.3892/mmr.2023.13113
- Article Number: 226
-
Copyright: © Dix-Peek et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
|
Gurdasani D, Carstensen T, Tekola-Ayele F, Pagani L, Tachmazidou I, Hatzikotoulas K, Karthikeyan S, Iles L, Pollard MO, Choudhury A, et al: The African Genome Variation Project shapes medical genetics in Africa. Nature. 517:327–332. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gurdasani D, Barroso I, Zeggini E and Sandhu MS: Genomics of disease risk in globally diverse populations. Nat Rev Genet. 20:520–535. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Rotimi SO, Rotimi OA and Salhia B: A Review of cancer genetics and genomics studies in Africa. Front Oncol. 10:6064002021. View Article : Google Scholar : PubMed/NCBI | |
|
Hayat M, Chen WC, Brandenburg JT, Babb de Villiers C, Ramsay M and Mathew CG: Genetic susceptibility to breast cancer in Sub-Saharan African populations. JCO Glob Oncol. 7:1462–1471. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma R: Breast cancer burden in Africa: Evidence from GLOBOCAN 2018. J Public Health (Oxf). 43:763–771. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
South African National Cancer Registry. National Cancer Registry, . Cancer in South Africa 2019. https://www.nicd.ac.za/wp-content/uploads/2021/12/NCR_Path_2019_Full_Report_8dec2021.pdfMay 13–2022 | |
|
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B and King MC: Linkage of Early-onset familial breast cancer to chromosome 17q21. Science. 250:1684–1689. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 265:2088–2090. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Shiovitz S and Korde LA: Genetics of breast cancer: A topic in evolution. Ann Oncology. 26:1291–1299. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mavaddat N, Antoniou AC, Easton DF and Garcia-Closas M: Genetic susceptibility to breast cancer. Mol Oncol. 4:174–191. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Eygelaar D, van Rensburg EJ and Joubert F: Germline sequence variants contributing to cancer susceptibility in South African breast cancer patients of African ancestry. Sci Rep. 12:8022022. View Article : Google Scholar : PubMed/NCBI | |
|
Francies FZ, Wainstein T, De Leeneer K, Cairns A, Murdoch M, Nietz S, Cubasch H, Poppe B, Van Maerken T, Crombez B, et al: BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer. BMC Cancer. 15:9122015. View Article : Google Scholar : PubMed/NCBI | |
|
Van der Merwe NC, Combrink HME, Ntaita KS and Oosthuizen J: Prevalence of clinically relevant germline BRCA variants in a large unselected South African breast and ovarian cancer cohort: A public sector experience. Front Genet. 13:8342652022. View Article : Google Scholar : PubMed/NCBI | |
|
Van Der Merwe NC, Oosthuizen J, Theron M, Chong G and Foulkes WD: The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer. BMC Cancer. 20:3912020. View Article : Google Scholar : PubMed/NCBI | |
|
Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, et al: Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nat Genet. 52:56–73. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, et al: Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 52:572–581. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Easton DF, Pooley KA, Dunning AM, Pharoah PDP, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 447:1087–1093. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wang Z, Welch R, Hutchinson A, Wang J, et al: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 39:870–874. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou WY, Zheng H, Du XL and Yang JL: Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients. Cancer Biol Med. 13:260–268. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Katoh Y and Katoh M: FGFR2-related pathogenesis and FGFR2-targeted therapeutics (Review). Int J Mol Med. 23:307–311. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang Q, Bolla MK, et al: FGF receptor genes and breast cancer susceptibility: Results from the Breast Cancer Association Consortium. Br J Cancer. 110:1088–1100. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mountjoy E, Schmidt EM, Carmona M, Schwartzentruber J, Peat G, Miranda A, Fumis L, Hayhurst J, Buniello A, Karim MA, et al: An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat Genet. 53:1527–1533. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, Doody DR, MacArthur S, Tyrer J, Pharoah PD, et al: FGFR2 variants and breast cancer risk: Fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet. 18:1692–1703. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, et al: Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 104:21–34. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
AlRaddadi RIR, Alamri RJN, Shebli WTY, Fallatah EIY, Alhujaily AS, Mohamed HS and Alotibi MKH: Fibroblast growth factor receptor 2 gene (FGFR2) rs2981582T/C polymorphism and susceptibility to breast cancer in Saudi women. Saudi J Biol Sci. 28:6112–6115. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liang H, Yang X, Chen L, Li H, Zhu A, Sun M, Wang H and Li M: Heterogeneity of breast cancer associations with common genetic variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women. Biomed Res Int. 2015:6269482015. View Article : Google Scholar : PubMed/NCBI | |
|
Han W, Woo JH, Yu JH, Lee MJ, Moon HG, Kang D and Noh DY: Common genetic variants associated with breast cancer in korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol Biomarkers Prev. 20:793–798. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Purnomosari D, Raharjo C, Kalim AS, Herviastuti R, Yushan M, Fajar RA, Harris KK and Wahyono A: P21 Ser31Arg and FGFR2 rs2981582 polymorphisms as risk factors for early onset of breast cancer in Yogyakarta, Indonesia. Asian Pac J Cancer Prev. 20:3305–3309. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Brignoni L, Cappetta M, Colistro V, Sans M, Artagaveytia N, Bonilla C and Bertoni B: Genomic diversity in sporadic breast cancer in a Latin American population. Genes (Basel). 11:12722020. View Article : Google Scholar : PubMed/NCBI | |
|
Özgöz A, Mutlu İçduygu F, Yükseltürk A, ŞamlI H, Hekİmler Öztürk K and Başkan Z: Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer. J Genet. 99:152020. View Article : Google Scholar : PubMed/NCBI | |
|
Hodoǧlugil U and Mahley RW: Turkish population structure and genetic ancestry reveal relatedness among eurasian populations. Ann Hum Genet. 76:128–141. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, Prathalingham R, Dennis J, Bolla MK, Wang Q, et al: Fine-scale mapping of the FGFR2 breast cancer risk locus: Putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet. 93:1046–1060. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Campbell TM, Castro MAA, De Santiago I, Fletcher MNC, Halim S, Prathalingam R, Ponder BAJ and Meyer KB: FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness. Carcinogenesis. 37:741–750. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lu P, Hankel IL, Hostager BS, Swartzendruber JA, Friedman AD, Brenton JL, Rothman PB and Colgan JD: The developmental regulator protein Gon4l associates with protein YY1, co-repressor Sin3a, and histone deacetylase 1 and mediates transcriptional repression. J Biol Chem. 286:18311–18319. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C and Ponder BA: Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol. 6:e1082008. View Article : Google Scholar : PubMed/NCBI | |
|
Owens TW, Rogers RL, Best SA, Ledger A, Mooney AM, Ferguson A, Shore P, Swarbrick A, Ormandy CJ, Simpson PT, et al: Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. Cancer Res. 74:5277–5286. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu X, Asa SL and Ezzat S: Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. Mol Endocrinol. 23:1397–1405. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ogura T, Azuma K, Sato J, Kinowaki K, Takayama KI, Takeiwa T, Kawabata H and Inoue S: OCT1 is a poor prognostic factor for breast cancer patients and promotes cell proliferation via inducing NCAPH. Int J Mol Sci. 22:115052021. View Article : Google Scholar : PubMed/NCBI | |
|
Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ and Millikan RC: FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis. 31:1417–1423. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bryc K, Durand EY, Macpherson JM, Reich D and Mountain JL: The genetic ancestry of African Americans, Latinos, and European Americans across the United States. Am J Hum Genet. 96:37–53. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zakharia F, Basu A, Absher D, Assimes TL, Go AS, Hlatky MA, Iribarren C, Knowles JW, Li J, Narasimhan B, et al: Characterizing the admixed African ancestry of African Americans. Genome Biol. 10:R1412009. View Article : Google Scholar : PubMed/NCBI | |
|
Cubasch H, Ruff P, Joffe M, Norris S, Chirwa T, Nietz S, Sharma V, Duarte R, Buccimazza I, Čačala S, et al: South African breast cancer and HIV outcomes study: Methods and baseline assessment. J Glob Oncol. 3:114–124. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Zeng X, Liu P, Hong R, Lu H, Ji H, Lu L and Li Y: Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: A meta-analysis. Oncotarget. 8:3454–3470. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Lu H, Ji H, Lu L, Liu P, Hong R and Li Y: Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis. Medicine (Baltimore). 96:9–13. 2017. View Article : Google Scholar | |
|
1000 Genomes Project Consortium, . Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA and Abecasis GR: A global reference for human genetic variation. Nature. 526:68–74. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, Limou S, Sezgin E, Nelson GW, Fogo AB, et al: APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans. J Am Soc Nephrol. 26:2882–2890. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
He C, Holme J and Anthony J: SNP genotyping: The KASP assay. Methods Mol Biol. 1145:75–86. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fitzgibbons PL, Connolly JL, Bose S, Chen YY, de Baca ME, Edgerton M, Hayes DF, Hil KA, Lester SC, Simpson JF, et al: Protocol for the examination of resection specimens from patients with invasive carcinoma of the breast. College of American Pathologists; Northfield (IL): 2020 | |
|
Fitzgibbons PL, Dillon DA, Alsabeh R, Berman MA, Hayes DF, Hicks DG, Hughes KS and Nofech-Mozes S: Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. Arch Pathol Lab Med. 138:595–601. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B and Senn HJ: Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 22:1736–1747. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Department of Health Republic of South Africa, . Clinical Guidelines for Breast Cancer Control and Management, 1–123 2018. Available from. https://cansa.org.za/files/2019/08/DOH-Breast-Cancer-Guidelines-Final.pdfAugust 31–2022 | |
|
Suvarna SK, Layton C and Bancroft JD: Bancroft's Theory and Practice of Histological Techniques. 8th edition. Elsevier; 2019 | |
|
Dix-Peek T, Phakathi BP, van den Berg EJ, Dickens C, Augustine TN, Cubasch H, Neugut AI, Jacobson JS, Joffe M, Ruff P and Duarte RAB: Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Res Treat. 199:1–12. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Lewis CM: Genetic association studies: Design, analysis and interpretation. Brief Bioinform. 3:146–153. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Stender JD, Frasor J, Komm B, Chang KCN, Kraus WL and Katzenellenbogen BS: Estrogen-regulated gene networks in human breast cancer cells: Involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol. 21:2112–2123. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, et al: Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 163:506–519. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, et al: The genetic structure and history of Africans and African Americans. Science. 324:1035–1044. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Martin AR, Gignoux CR, Walters RK, Wojcik GL, Neale BM, Gravel S, Daly MJ, Bustamante CD and Kenny EE: Human demographic history impacts genetic risk prediction across diverse populations. Am J Hum Genet. 100:635–649. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dai CL, Vazifeh MM, Yeang CH, Tachet R, Wells RS, Vilar MG, Daly MJ, Ratti C and Martin AR: Population histories of the United States revealed through fine-scale migration and haplotype analysis. Am J Hum Genet. 106:371–388. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zimmerman KD, Schurr TG, Chen WM, Nayak U, Mychaleckyj JC, Quet Q, Moultrie LH, Divers J, Keene KL, Kamen DL, et al: Genetic landscape of Gullah African Americans. Am J Phys Anthropol. 175:905–919. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sucheston LE, Bensen JT, Xu Z, Singh PK, Preus L, Mohler JL, Su LJ, Fontham ET, Ruiz B, Smith GJ and Taylor JA: Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort. PLoS One. 7:e309502012. View Article : Google Scholar : PubMed/NCBI | |
|
Choudhury A, Aron S, Botigué LR, Sengupta D, Botha G, Bensellak T, Wells G, Kumuthini J, Shriner D, Fakim YJ, et al: High-depth African genomes inform human migration and health. Nature. 586:741–748. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Busby GB, Band G, Si Le Q, Jallow M, Bougama E, Mangano VD, Amenga-Etego LN, Enimil A, Apinjoh T, Ndila CM, et al: Admixture into and within sub-Saharan Africa. Elife. 5:e152662016. View Article : Google Scholar : PubMed/NCBI | |
|
Fernández-Nogueira P, Mancino M, Fuster G, López-Plana A, Jauregui P, Almendro V, Enreig E, Menéndez S, Rojo F, Noguera-Castells A, et al: Tumor-associated fibroblasts promote HER2-targeted therapy resistance through FGFR2 activation. Clin Cancer Res. 26:1432–1448. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hanker AB, Garrett JT, Estrada MV, Moore PD, Ericsson PG, Koch JP, Langley E, Singh S, Kim PS, Frampton GM, et al: HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2. Clin Cancer Res. 23:4323–4334. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Phakathi B, Cubasch H, Nietz S, Dickens C, Dix-Peek T, Joffe M, Neugut AI, Jacobson J, Duarte R and Ruff P: Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV. Breast. 43:123–129. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Achilonu OJ, Singh E, Nimako G, Eijkemans RMJC and Musenge E: Rule-based information extraction from free-text pathology reports reveals trends in South African female breast cancer molecular subtypes and Ki67 expression. Biomed Res Int. 2022:61578612022. View Article : Google Scholar : PubMed/NCBI | |
|
May A, Hazelhurst S, Li Y, Norris SA, Govind N, Tikly M, Hon C, Johnson KJ, Hartmann N, Staedtler F and Ramsay M: Genetic diversity in black South Africans from Soweto. BMC Genomics. 14:6442013. View Article : Google Scholar : PubMed/NCBI |
